These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27992301)

  • 1. Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.
    Ovenden ES; Drögemöller BI; van der Merwe L; Chiliza B; Asmal L; Emsley RA; Warnich L
    Pharmacogenomics; 2017 Jan; 18(2):105-120. PubMed ID: 27992301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    McGregor N; Thompson N; O'Connell KS; Emsley R; van der Merwe L; Warnich L
    Psychiatry Res; 2018 Apr; 262():141-148. PubMed ID: 29448178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.
    Drögemöller BI; Emsley R; Chiliza B; van der Merwe L; Wright GE; Daya M; Hoal E; Malhotra AK; Lencz T; Robinson DG; Zhang JP; Asmal L; Niehaus DJ; Warnich L
    Pharmacogenet Genomics; 2016 May; 26(5):235-42. PubMed ID: 26928376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic overlap between antipsychotic response and susceptibility to schizophrenia.
    Ikeda M; Yoshimura R; Hashimoto R; Kondo K; Saito T; Shimasaki A; Ohi K; Tochigi M; Kawamura Y; Nishida N; Miyagawa T; Sasaki T; Tokunaga K; Kasai K; Takeda M; Nakamura J; Ozaki N; Iwata N
    J Clin Psychopharmacol; 2015 Feb; 35(1):85-8. PubMed ID: 25502484
    [No Abstract]   [Full Text] [Related]  

  • 5. GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma.
    Koga A; Bani-Fatemi A; Hettige N; Borlido C; Zai C; Strauss J; Gerretsen P; Graff A; Remington G; De Luca V
    Pharmacogenomics; 2017 May; 18(7):663-671. PubMed ID: 28453389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia.
    Chiliza B; Asmal L; Kilian S; Phahladira L; Emsley R
    Hum Psychopharmacol; 2015 May; 30(3):173-82. PubMed ID: 25758549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study.
    Koga AT; Strauss J; Zai C; Remington G; De Luca V
    J Neural Transm (Vienna); 2016 Mar; 123(3):329-38. PubMed ID: 26821981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
    Clark SL; Souza RP; Adkins DE; Aberg K; Bukszár J; McClay JL; Sullivan PF; van den Oord EJ
    Pharmacogenet Genomics; 2013 Feb; 23(2):69-77. PubMed ID: 23241943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of genome-wide association studies of antipsychotic response.
    Allen JD; Bishop JR
    Pharmacogenomics; 2019 Mar; 20(4):291-306. PubMed ID: 30883267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
    Chiliza B; Ojagbemi A; Esan O; Asmal L; Oosthuizen P; Kidd M; Gureje O; Emsley R
    Early Interv Psychiatry; 2016 Feb; 10(1):54-62. PubMed ID: 24690088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
    Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
    Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort.
    O'Connell KS; McGregor NW; Malhotra A; Lencz T; Emsley R; Warnich L
    Pharmacogenomics J; 2019 Feb; 19(1):109-114. PubMed ID: 30032160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.
    Watanabe J; Fukui N; Suzuki Y; Sugai T; Ono S; Tsuneyama N; Saito M; Tajiri M; Someya T
    J Clin Psychopharmacol; 2017 Aug; 37(4):452-455. PubMed ID: 28590366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain.
    Zai CC; Tiwari AK; Chowdhury NI; Brandl EJ; Shaikh SA; Freeman N; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL
    J Clin Psychopharmacol; 2015 Feb; 35(1):7-12. PubMed ID: 25514066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
    Lavedan C; Licamele L; Volpi S; Hamilton J; Heaton C; Mack K; Lannan R; Thompson A; Wolfgang CD; Polymeropoulos MH
    Mol Psychiatry; 2009 Aug; 14(8):804-19. PubMed ID: 18521090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia.
    Kang SG; Lee HJ; Park YM; Yang HJ; Song HM; Lee YJ; Cho SJ; Cho SN; Kim L
    Hum Psychopharmacol; 2013 Mar; 28(2):117-23. PubMed ID: 23361623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia.
    Mouaffak F; Kebir O; Bellon A; Gourevitch R; Tordjman S; Viala A; Millet B; Jaafari N; Olié JP; Krebs MO
    Pharmacogenomics; 2011 Feb; 12(2):185-93. PubMed ID: 21332312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.